Protein Tyrosine Kinases

From Inhibitors to Useful Drugs

Editors:

ISBN: 978-1-58829-384-8 (Print) 978-1-59259-962-2 (Online)

Table of contents (11 chapters)

  1. Front Matter

    Pages i-xiii

  2. No Access

    Book Chapter

    Pages 1-29

    Protein Tyrosine Kinases as Targets for Cancer and Other Indications

  3. No Access

    Book Chapter

    Pages 31-52

    Inhibitors of Signaling Interfaces

  4. No Access

    Book Chapter

    Pages 53-69

    PI3-Kinase Inhibition

  5. No Access

    Book Chapter

    Pages 71-92

    Src as a Target for Pharmaceutical Intervention

  6. No Access

    Book Chapter

    Pages 93-113

    Activated FLT3 Receptor Tyrosine Kinase as a Therapeutic Target In Leukemia

  7. No Access

    Book Chapter

    Pages 115-144

    JAK Kinases in Leukemias, Lymphomas, and Multiple Myeloma

  8. No Access

    Book Chapter

    Pages 145-160

    Glivec® (Gleevec®, Imatinib, STI571)

  9. No Access

    Book Chapter

    Pages 161-186

    Platelet-Derived Growth Factor

  10. No Access

    Book Chapter

    Pages 187-230

    Structural Biology of Protein Tyrosine Kinases

  11. No Access

    Book Chapter

    Pages 231-264

    Testing of Signal Transduction Inhibitors in Animal Models of Cancer

  12. No Access

    Book Chapter

    Pages 265-278

    Phosphoproteomics in Drug Discovery and Development

  13. Back Matter

    Pages 279-290